Limited redundancy in genes regulated by Cyclin T2 and Cyclin T1

BMC Research Notes

Volumn 4, Issue , 2011, Pages

  Ramakrishnan, Rajesh ^a   Yu, Wendong ^a,b   Rice, Andrew P ^a  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1; LENTIVIRUS;

EID: 79960676989     PISSN: None     EISSN: 17560500     Source Type: Journal    
DOI: 10.1186/1756-0500-4-260     Document Type: Article

References (49)

1. Controlling the elongation phase of transcription with P-TEFb. Peterlin BM, Price DH, Mol Cell 2006 23 297 305 10.1016/j.molcel.2006.06.014 16885020 (Pubitemid 44128850)
2. The Yin and Yang of P-TEFb regulation: implications for human immunodeficiency virus gene expression and global control of cell growth and differentiation. Zhou Q, Yik JH, Microbiol Mol Biol Rev 2006 70 646 659 10.1128/MMBR.00011-06 16959964 (Pubitemid 44484688)
3. A chromatin landmark and transcription initiation at most promoters in human cells. Guenther MG, Levine SS, Boyer LA, Jaenisch R, Young RA, Cell 2007 130 77 88 10.1016/j.cell.2007.05.042 17632057 (Pubitemid 47031323)
4. Control of inducible gene expression by signal-dependent transcriptional elongation. Hargreaves DC, Horng T, Medzhitov R, Cell 2009 138 129 145 10.1016/j.cell.2009.05.047 19596240
5. RNA-driven cyclin-dependent kinase regulation: when CDK9/cyclin T subunits of P-TEFb meet their ribonucleoprotein partners. Michels AA, Bensaude O, Biotechnol J 2008 3 1022 1032 10.1002/biot.200800104 18655042
6. Phosphorylated positive transcription elongation factor b (P-TEFb) is tagged for inhibition through association with 7SK snRNA. Chen R, Yang Z, Zhou Q, J Biol Chem 2004 279 4153 4160 14627702 (Pubitemid 38199000)
7. T-loop phosphorylated Cdk9 localizes to nuclear speckle domains which may serve as sites of active P-TEFb function and exchange between the Brd4 and 7SK/HEXIM1 regulatory complexes. Dow EC, Liu H, Rice AP, J Cell Physiol 2010 224 84 93 20201073
8. Cyclin T1 but not cyclin T2a is induced by a post-transcriptional mechanism in PAMP-activated monocyte-derived macrophages. Liou LY, Haaland RE, Herrmann CH, Rice AP, J Leukoc Biol 2006 79 388 396 16330531 (Pubitemid 44831171)
9. miR-198 inhibits HIV-1 gene expression and replication in monocytes and its mechanism of action appears to involve repression of cyclin T1. Sung TL, Rice AP, PLoS Pathog 2009 5 1000263 10.1371/journal.ppat.1000263 19148268
10. Induction of the HIV-1 Tat co-factor cyclin T1 during monocyte differentiation is required for the regulated expression of a large portion of cellular mRNAs. Yu W, Wang Y, Shaw CA, Qin XF, Rice AP, Retrovirology 2006 3 32 10.1186/1742-4690-3-32 16764723 (Pubitemid 44314225)
11. Tat-associated kinase, TAK, activity is regulated by distinct mechanisms in peripheral blood lymphocytes and promonocytic cell lines. Herrmann CH, Carroll RG, Wei P, Jones KA, Rice AP, J Virol 1998 72 9881 9888 9811724 (Pubitemid 28520854)
12. Effects of prostratin on Cyclin T1/P-TEFb function and the gene expression profile in primary resting CD4+ T cells. Sung TL, Rice AP, Retrovirology 2006 3 66 10.1186/1742-4690-3-66 17014716 (Pubitemid 44575524)
13. Cyclin T1 expression is regulated by multiple signaling pathways and mechanisms during activation of human peripheral blood lymphocytes. Marshall RM, Salerno D, Garriga J, Grana X, J Immunol 2005 175 6402 6411 16272292 (Pubitemid 41598880)
14. Cyclin T1-dependent genes in activated CD4 T and macrophage cell lines appear enriched in HIV-1 co-factors. Yu W, Ramakrishnan R, Wang Y, Chiang K, Sung TL, Rice AP, PLoS ONE 2008 3 3146 10.1371/journal.pone.0003146 18773076
15. Inhibition of HIV-1 replication by P-TEFb inhibitors DRB, seliciclib and flavopiridol correlates with release of free P-TEFb from the large, inactive form of the complex. Biglione S, Byers SA, Price JP, Nguyen VT, Bensaude O, Price DH, Maury W, Retrovirology 2007 4 47 10.1186/1742-4690-4-47 17625008 (Pubitemid 47277974)
16. Flavopiridol inhibits P-TEFb and blocks HIV-1 replication. Chao SH, Fujinaga K, Marion JE, Taube R, Sausville EA, Senderowicz AM, Peterlin BM, Price DH, J Biol Chem 2000 275 28345 28348 10906320
17. Inhibition of human immunodeficiency virus type 1 replication by RNA interference directed against human transcription elongation factor P-TEFb (CDK9/CyclinT1). Chiu YL, Cao H, Jacque JM, Stevenson M, Rana TM, J Virol 2004 78 2517 2529 10.1128/JVI.78.5.2517-2529.2004 14963154 (Pubitemid 38228946)
18. Host-cell positive transcription elongation factor b kinase activity is essential and limiting for HIV type 1 replication. Flores O, Lee G, Kessler J, Miller M, Schlief W, Tomassini J, Hazuda D, Proc Natl Acad Sci USA 1999 96 7208 7213 10.1073/pnas.96.13.7208 10377393 (Pubitemid 29299640)
19. Antiapoptotic function of Cdk9 (TAK/P-TEFb) in U937 promonocytic cells. Foskett SM, Ghose R, Tang DN, Lewis DE, Rice AP, J Virol 2001 75 1220 1228 10.1128/JVI.75.3.1220-1228.2001 11152495 (Pubitemid 32094681)
20. Indirubin-3'-monoxime, a derivative of a Chinese antileukemia medicine, inhibits P-TEFb function and HIV-1 replication. Heredia A, Davis C, Bamba D, Le N, Gwarzo MY, Sadowska M, Gallo RC, Redfield RR, AIDS 2005 19 2087 2095 10.1097/01.aids.0000194805.74293.11 16284457 (Pubitemid 41668996)
21. Direct inhibition of CDK9 blocks HIV-1 replication without preventing T-cell activation in primary human peripheral blood lymphocytes. Salerno D, Hasham MG, Marshall R, Garriga J, Tsygankov AY, Grana X, Gene 2007 405 65 78 10.1016/j.gene.2007.09.010 17949927 (Pubitemid 350016664)
22. Transcription inhibition by flavopiridol: mechanism of chronic lymphocytic leukemia cell death. Chen R, Keating MJ, Gandhi V, Plunkett W, Blood 2005 106 2513 2519 10.1182/blood-2005-04-1678 15972445 (Pubitemid 41510827)
23. Mechanism of action of SNS-032, a novel cyclin-dependent kinase inhibitor, in chronic lymphocytic leukemia. Chen R, Wierda WG, Chubb S, Hawtin RE, Fox JA, Keating MJ, Gandhi V, Plunkett W, Blood 2009 113 4637 4645 10.1182/blood-2008-12-190256 19234140
24. Xylocydine, a novel Cdk inhibitor, is an effective inducer of apoptosis in hepatocellular carcinoma cells in vitro and in vivo. Cho SJ, Lee SS, Kim YJ, Park BD, Choi JS, Liu L, Ham YM, Moon Kim B, Lee SK, Cancer Lett 2010 287 196 206 10.1016/j.canlet.2009.06.011 19616371
25. Cell cycle kinases as therapeutic targets for cancer. Lapenna S, Giordano A, Nat Rev Drug Discov 2009 8 547 566 10.1038/nrd2907 19568282
26. 55K isoform of CDK9 associates with Ku70 and is involved in DNA repair. Liu H, Herrmann CH, Chiang K, Sung TL, Moon SH, Donehower LA, Rice AP, Biochem Biophys Res Commun 2010 397 245 250 10.1016/j.bbrc.2010.05.092 20493174
27. Cyclin T2 is essential for mouse embryogenesis. Kohoutek J, Li Q, Blazek D, Luo Z, Jiang H, Peterlin BM, Mol Cell Biol 2009 29 3280 3285 10.1128/MCB.00172-09 19364821
28. Rational siRNA design for RNA interference. Reynolds A, Leake D, Boese Q, Scaringe S, Marshall WS, Khvorova A, Nat Biotechnol 2004 22 326 330 10.1038/nbt936 14758366 (Pubitemid 38295766)
29. Identification of multiple cyclin subunits of human P-TEFb. Peng J, Zhu Y, Milton JT, Price DH, Genes Dev 1998 12 755 762 10.1101/gad.12.5.755 9499409 (Pubitemid 28134306)
30. Accuracy of cDNA microarray methods to detect small gene expression changes induced by neuregulin on breast epithelial cells. Yao B, Rakhade SN, Li Q, Ahmed S, Krauss R, Draghici S, Loeb JA, BMC Bioinformatics 2004 5 99 10.1186/1471-2105-5-99 15272935 (Pubitemid 40195405)
31. Accuracy and calibration of commercial oligonucleotide and custom cDNA microarrays. Yuen T, Wurmbach E, Pfeffer RL, Ebersole BJ, Sealfon SC, Nucleic Acids Res 2002 30 48 10.1093/nar/30.10.e48 12000853
32. Chronic insulin treatment of diabetes does not fully normalize alterations in the retinal transcriptome. Bixler GV, Vanguilder HD, Brucklacher RM, Kimball SR, Bronson SK, Freeman WM, BMC Med Genomics 2011 4 40 10.1186/1755-8794-4-40 21575160
33. Multi-modal proteomic analysis of retinal protein expression alterations in a rat model of diabetic retinopathy. VanGuilder HD, Bixler GV, Kutzler L, Brucklacher RM, Bronson SK, Kimball SR, Freeman WM, PLoS One 2011 6 16271 10.1371/journal.pone.0016271 21249158
34. Flavopiridol inactivates P-TEFb and blocks most RNA polymerase II transcription in vivo. Chao SH, Price DH, J Biol Chem 2001 276 31793 31799 10.1074/jbc.M102306200 11431468
35. Cyclin T: three forms for different roles in physiological and pathological functions. De Luca A, De Falco M, Baldi A, Paggi MG, J Cell Physiol 2003 194 101 107 10.1002/jcp.10196 12494448 (Pubitemid 36043624)
36. MyoD recruits the cdk9/cyclin T2 complex on myogenic-genes regulatory regions. Giacinti C, Bagella L, Puri PL, Giordano A, Simone C, J Cell Physiol 2006 206 807 813 10.1002/jcp.20523 16245309 (Pubitemid 43191056)
37. CDK-9/cyclin T (P-TEFb) is required in two postinitiation pathways for transcription in the C. elegans embryo. Shim EY, Walker AK, Shi Y, Blackwell TK, Genes Dev 2002 16 2135 2146 10.1101/gad.999002 12183367
38. Transient induction of cyclin T1 during human macrophage differentiation regulates human immunodeficiency virus type 1 Tat transactivation function. Liou LY, Herrmann CH, Rice AP, J Virol 2002 76 10579 10587 10.1128/JVI.76.21.10579- 10587.2002 12368300 (Pubitemid 35176174)
39. Regulation of TAK/P-TEFb in CD4+ T lymphocytes and macrophages. Rice AP, Herrmann CH, Curr HIV Res 2003 1 395 404 10.2174/1570162033485159 15049426
40. P-TEFb containing cyclin K and Cdk9 can activate transcription via RNA. Lin X, Taube R, Fujinaga K, Peterlin BM, J Biol Chem 2002 277 16873 16878 10.1074/jbc.M200117200 11884399 (Pubitemid 34967712)
41. A role for cdk9-cyclin k in maintaining genome integrity. Yu DS, Cortez D, Cell Cycle 2011 10 28 32 10.4161/cc.10.1.14364 21200140
42. Selective control of gene expression by CDK9 in human cells. Garriga J, Xie H, Obradovic Z, Grana X, J Cell Physiol 2010 222 200 208 10.1002/jcp.21938 19780058
43. The human immunodeficiency virus Tat proteins specifically associate with TAK in vivo and require the carboxyl-terminal domain of RNA polymerase II for function. Yang X, Herrmann CH, Rice AP, J Virol 1996 70 4576 4584 8676484
44. Inhibiting HIV-1 infection in human T cells by lentiviral-mediated delivery of small interfering RNA against CCR5. Qin XF, An DS, Chen IS, Baltimore D, Proc Natl Acad Sci USA 2003 100 183 188 10.1073/pnas.232688199 12518064 (Pubitemid 36078049)
45. Evaluation of methods for oligonucleotide array data via quantitative real-time PCR. Qin LX, Beyer RP, Hudson FN, Linford NJ, Morris DE, Kerr KF, BMC Bioinformatics 2006 7 23 10.1186/1471-2105-7-23 16417622 (Pubitemid 43205344)
46. MAPPFinder: using Gene Ontology and GenMAPP to create a global gene-expression profile from microarray data. Doniger SW, Salomonis N, Dahlquist KD, Vranizan K, Lawlor SC, Conklin BR, Genome Biol 2003 4 7 10.1186/gb-2003-4-1-r7 12540299
47. DAVID: Database for Annotation, Visualization, and Integrated Discovery. Dennis G, Sherman BT, Hosack DA, Yang J, Gao W, Lane HC, Lempicki RA, Genome Biol 2003 4 3 10.1186/gb-2003-4-5-p3 12734009
48. Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Huang da W, Sherman BT, Lempicki RA, Nat Protoc 2009 4 44 57 19131956
49. siRNA depletion of 7SK snRNA induces apoptosis but does not affect expression of the HIV-1 LTR or P-TEFb-dependent cellular genes. Haaland RE, Herrmann CH, Rice AP, J Cell Physiol 2005 205 463 470 10.1002/jcp.20528 16152622 (Pubitemid 41598861)